How Much Does Psychedelic Therapy Cost in 2026?

What Is Psychedelic Assisted Therapy

Psychedelic assisted therapy combines therapeutic support with psychoactive substances to address root causes of mental health conditions. It is a treatment model where a medicine is administered within a protocol-driven therapeutic framework that includes medical screening, preparation, supervised dosing, and integration support. Licensed professionals guide you through each phase to ensure safety and maximize the therapeutic benefits of the experience.

Three primary modalities exist within this landscape, each operating under different regulatory frameworks:

• Ketamine: This dissociative medicine has been FDA-approved as an anesthetic since 1970¹ and has been on the World Health Organization List of Essential Medicines since 1985.² In the United States, licensed physicians and other prescribers may order ketamine off-label for certain mental health conditions.
• Psilocybin: This naturally occurring compound is available through state-regulated service centers in Oregon and Colorado, where licensed facilitators supervise sessions.
• MDMA: This compound remains largely restricted to research trials or expanded-access programs, primarily for post-traumatic stress disorder.

The cost of psychedelic therapy is driven primarily by the care infrastructure around the medicine, not the substance itself. This distinction is essential for understanding the price ranges that follow.

Why Psychedelic Therapy Costs More Than the Medicine

The raw cost of the medicine is a small fraction of the total price. The majority of the expense comes from professional labor, medical oversight, safety protocols, and facility infrastructure. Licensed professionals dedicate anywhere from two to eight hours per dosing session, and forty or more hours across a full MDMA course, to guide patients through each phase.

Several primary cost drivers apply across all modalities:

• Medical screening and intake: Licensed prescribers conduct thorough psychiatric and physical evaluations to assess treatment appropriateness, individual risk factors, and patient safety.
• Preparation sessions: Guides or therapists conduct pre-dosing sessions to prepare your mindset and environment before dosing.
• Supervised dosing: Licensed professionals actively monitor patients during dosing sessions, which can last from two to eight hours depending on the substance.
• Integration support: Post-session therapy or coaching helps patients translate their insights into lasting behavioral changes.
• Facility and licensing overhead: Physical clinic spaces, state licensing fees, specialized insurance, and regulatory compliance costs add to the provider's operating expenses.

Once you count the hours of professional care baked into each price, the wide spread across treatment types and settings stops looking arbitrary.

Typical Psychedelic Therapy Costs by Treatment Type

Substance, setting, and supervision level are what separate a $165 session from a $3,000 one. The ranges below reflect what a person can expect to pay in the United States for a course of treatment, not a single dose.

Ketamine Therapy Cost Range

Ketamine therapy is available through several delivery methods, each with a different cost structure. These include intravenous infusions at in-clinic settings, sublingual or subcutaneous at-home programs, and esketamine nasal spray at certified clinics.

Intravenous ketamine infusions typically cost between $400 and $800 per session, translating to $2,400 to $4,800 for a standard initial course of six sessions. This pricing generally covers in-clinic monitoring and medical time, but preparation and integration therapy are often billed separately. Esketamine nasal spray, marketed as Spravato, is typically priced between $600 and $900 per session without insurance. It requires administration at a certified clinic under a Risk Evaluation and Mitigation Strategy, which is an FDA risk-management program requiring in-clinic monitoring for at least two hours.⁸

At-home ketamine programs represent a more affordable alternative, with courses running roughly $500 to $1,300 for a six-session program. These programs typically bundle provider consults, coaching, integration support, and session materials into the price. Mindbloom offers both sublingual tablets and subcutaneous injectables for at-home use, with programs starting at $165 per session for an 18-session program.

Setting, support level, and delivery method account for nearly all of the spread between ketamine options; the medicine costs roughly the same either way.

Psilocybin Therapy Cost Range

Legal psilocybin therapy is currently available through state-regulated service centers in Oregon and Colorado, and through international retreats in countries where psilocybin is legal or decriminalized.

At state-regulated service centers, a single facilitated psilocybin session typically costs between $1,000 and $3,000. This price includes mandatory preparation, a facilitated dosing session lasting five to eight hours, and a follow-up integration session. High state licensing fees and local taxes, such as Oregon's fifteen percent psilocybin tax, are built directly into these prices. Some centers offer group psilocybin sessions, which can lower the per-person cost to approximately $400 to $750.

International retreats in countries like Jamaica, Costa Rica, or the Netherlands generally range from $1,875 to $10,500 for multi-day packages. These prices typically include lodging, meals, and group facilitation, but they do not cover airfare or travel expenses.

Five to eight hours of one-on-one facilitation, billed at professional rates, is what separates a psilocybin session's price from a ketamine session's. For anyone outside Oregon or Colorado, travel costs add significantly to the total.

MDMA Assisted Therapy Cost Range

MDMA-assisted therapy follows a protocol that typically involves multiple preparation sessions, two to three full-day dosing sessions, and several integration sessions. Each dosing session lasts approximately eight hours and requires two licensed therapists to be present for the entire duration.

A full course of MDMA-assisted therapy is estimated at $11,000 to $15,000. Two therapists, forty-plus hours, no shortcuts. The requirement of a two-therapist team for forty or more hours of direct care drives the bulk of this expense. MDMA-assisted therapy is not yet FDA-approved and is primarily available through expanded-access programs or clinical trials, which severely limits legal access. Some researchers have evaluated group therapy protocols to reduce costs, showing potential staffing cost reductions of thirty-five to fifty-one percent.⁴

MDMA-assisted therapy is the most expensive modality per course because of the intensive staffing model. Legal access remains limited, which further constrains availability and pricing.

Why Location Changes the Total Cost of Psychedelic Therapy

Travel and lodging expenses often represent the largest hidden costs of legal psychedelic therapy. The sticker price of a psychedelic therapy session does not capture the full cost for most people. Because legal access to psilocybin and MDMA is limited to specific states or countries, many people must travel to receive treatment, and travel expenses can rival or exceed the therapy itself.

Ketamine is the only psychedelic therapy that can be legally prescribed and administered nationwide, including through clinician-supervised at-home programs. Psilocybin requires traveling to Oregon, Colorado, or an international destination, while MDMA access is even more restricted. For anyone not living in a legal jurisdiction, the real cost includes airfare, lodging, meals, and time away from work, on top of the session fee.

When comparing psychedelic therapy costs, the question is not just how much the session costs, but how much it costs to get there and back. Ketamine's nationwide at-home availability eliminates the travel burden entirely.

Living in a Legal State

Residents of Oregon, Colorado, or areas near established ketamine clinics face the lowest financial barrier to in-person care. Dosing sessions are priced at the local sticker rate without the added burden of flights or hotels. However, even local patients must account for the time commitment of multi-hour sessions, which may require taking a full day off work.

Traveling to a Legal Clinic

Individuals living in states without legal psilocybin frameworks must travel domestically to access regulated service centers. This journey requires booking round-trip flights, which average $350 to $600, and securing lodging for at least one to two nights. When adding meals and ground transportation, the total cost of a single psilocybin session can easily double. With travel included, a single domestic psilocybin session totals roughly $1,500 to $3,900.

Traveling Internationally

Traveling to international destinations like Jamaica, Costa Rica, or the Netherlands is often necessary to access specialized retreats. While these multi-day programs typically bundle lodging and meals into their pricing, international airfare adds $800 to $1,500 to the total expense. With airfare included, international retreats reach the highest total cost of any psychedelic therapy option, placing them out of reach for most people.

What Is Included in Psychedelic Therapy Pricing

Pricing reflects a bundle of medical and therapeutic services, not just the medicine. Two programs at similar price points can deliver very different experiences, because a lower sticker price often means essential components are billed separately.

A comprehensive psychedelic therapy program typically bundles several core components:

• Medical screening and eligibility evaluation: The psychiatric and physical assessment described above, billed as part of intake rather than separately.
• Prescriber consults: Initial and ongoing appointments with your prescribing physician to monitor progress and adjust dosing.
• Preparation sessions: Typically one to two pre-dosing sessions; confirm whether they are bundled or charged per hour.
• The medicine itself: The cost of the prescribed ketamine, psilocybin, or MDMA, including pharmacy compounding or service center dispensing fees.
• Supervised dosing session: Active monitoring by a licensed specialist, trained facilitator, or required support person during the active window of the medicine.
• Integration support: Post-session coaching, therapy, or group integration circles to help process the experience.
• Session materials or toolkit: Physical items such as eye masks, journals, and curated soundscapes to support the therapeutic setting.
• Ongoing access: Secure messaging with your care team and digital tools via a dedicated mobile application.

A lower sticker price sometimes means fewer of these components are included. When comparing options, ask what is bundled into the price and what costs extra.

How to Lower the Cost of Psychedelic Therapy

Psychedelic therapy is primarily an out-of-pocket expense, but tax-advantaged accounts and home-based care can meaningfully reduce the bill without compromising care quality.

Several strategies can help lower the total cost of treatment:

• Choose an at-home ketamine program: As the travel table above shows, this removes airfare, lodging, and clinic overhead from the total, typically the single largest reduction available.
• Use HSA or FSA funds: Ketamine prescribed by a licensed provider is typically an eligible expense for Health Savings Accounts and Flexible Spending Accounts.
• Check for insurance reimbursement: Some programs issue a superbill, an itemized receipt you can submit to your insurer for potential partial out-of-network reimbursement.
• Consider group sessions: Participating in group integration circles or group psilocybin sessions lowers the per-person cost of professional facilitation.
• Compare bundled value: A program that bundles provider consults, coaching, and integration may cost less in total than a cheaper program that charges for these services à la carte.

The most effective way to lower cost is to avoid paying for travel and clinic overhead. At-home ketamine therapy is the only modality that eliminates both.

Does Insurance Cover Psychedelic Therapy

Most commercial insurance plans do not cover psychedelic therapy directly. Coverage depends on the substance, the regulatory status of the treatment, and the specific insurance plan.

The insurance landscape varies significantly by modality:

• Ketamine: Because ketamine is prescribed off-label, commercial insurance rarely covers the treatment directly. However, off-label prescribing is a standard, widespread medical practice, accounting for approximately twenty-one percent of all prescriptions.⁵ Patients can often use HSA or FSA funds, or submit a superbill for potential out-of-network reimbursement.
• Spravato: As the only FDA-approved esketamine treatment, Spravato is covered by some commercial insurance plans. However, patients must meet strict criteria, obtain prior authorization, and receive treatment at a certified REMS clinic.
• Psilocybin: No commercial insurance plans currently cover psilocybin therapy. State-regulated programs in Oregon and Colorado are entirely out-of-pocket.
• MDMA: Because MDMA is not yet FDA-approved, it is not covered by insurance. Clinical trial participants may receive treatment at no cost, but enrollment is highly competitive.
• Medicare and Medicaid: Neither Medicare nor Medicaid currently covers psychedelic therapy for any modality, including off-label ketamine, Spravato, psilocybin, or MDMA.

Insurance coverage for psychedelic therapy is evolving slowly. Federal law would make an FDA-approved psilocybin or MDMA therapy eligible for mandatory Medicaid coverage, though low reimbursement rates make near-term implementation uncertain. In the near term, HSA or FSA eligibility and out-of-network reimbursement are the most practical pathways to offset costs for ketamine therapy specifically.

How Mindbloom Addresses Cost and Access

Mindbloom delivers a supervised at-home ketamine program that reduces the financial and geographic barriers to psychedelic care. The program uses a rigorous, protocol-driven framework designed to support appropriate care through medical screening, prescriber-directed treatment planning, and ongoing support. Mindbloom applies the screening, prescribing, and integration components described above, and adds a required peer treatment monitor who must be present for every session. No clinic visit is needed at any stage. Mindbloom is also the only at-home provider offering subcutaneous administration in addition to sublingual tablets.

Mindbloom offers programs of 6, 12, or 18 sessions, which clients select and purchase before meeting with a licensed provider for their medical evaluation. The 6-session program for new clients is priced at $215 per session, billed in monthly installments of $430 over three months, for a total of $1,290. The 12-session program is priced at $185 per session, billed as $370 per month over six months, for a total of $2,220. The 18-session program is priced at $165 per session, billed as $330 per month over nine months, for a total of $2,970. Continuing clients benefit from preferred pricing, paying $159 per session for a 6-session program or $129 per session for an 18-session program.

Building on decades of published research on ketamine's therapeutic applications, Mindbloom has released two of the largest peer-reviewed outcomes studies of at-home ketamine therapy to date.^6,7 In a peer-reviewed study of 11,441 Mindbloom clients using the Mindbloom protocol, eighty-nine percent of participants reported symptom improvement for depression and anxiety.⁷ Secondary outcome metrics from this study showed a fifty-six point four percent response rate and a twenty-eight point one percent remission rate.⁷ This builds on Mindbloom's initial peer-reviewed study of 1,247 clients, which similarly showed that eighty-nine percent of clients reported improvement in their symptoms.⁶ Clients can submit a superbill for potential out-of-network reimbursement, or apply HSA or FSA dollars to the full program cost.

Is Psychedelic Therapy Worth the Cost

The value of psychedelic therapy cannot be evaluated on sticker price alone. It depends on the quality of the care program, the strength of the evidence behind it, and the durability of the outcomes it produces.

When evaluating the investment, patients should consider three primary factors:

• Outcomes: Peer-reviewed research shows that supervised ketamine therapy programs produce rapid and durable symptom relief. In a study of 11,441 clients, eighty-nine percent reported symptom improvement for depression and anxiety, with benefits accumulating over a series of sessions.^6,7
• Support model: Programs that bundle medical screening, preparation, supervised dosing, and integration are designed to address the root causes of mental health conditions. This comprehensive approach is more likely to produce lasting change than medication-only models.
• Total cost of inaction: Untreated or undertreated mental health conditions carry significant financial and emotional costs, including lost productivity, ongoing medication expenses, and diminished quality of life.

The most expensive option is not always the most effective, and the cheapest is not always the best value. The right question is whether the program's structure, evidence, and support justify the investment.

Important Safety Information

Ketamine is not FDA-approved for PTSD, depression, or anxiety. Common side effects include dissociation, increased blood pressure, nausea, dizziness, and cognitive impairment. Ketamine has abuse potential and is not appropriate for patients with uncontrolled hypertension, psychotic disorders, or substance use disorders.⁹ Do not drive or operate machinery until the day after treatment. Individual results may vary. Full safety information: www.mindbloom.com/safety-information

Off-Label Use Disclosure

Ketamine is FDA-approved only as an anesthetic. Use for mental health conditions represents off-label prescribing by licensed clinicians based on clinical judgment. Schedule III Controlled Substance - DEA regulations apply.